ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Stomach Cancer
Cancer
Ovarian Cancer
Neoplasm Metastasis
Breast Cancer

Pancreatic Cancer trials near Rochester, MN, USA:

Claudin18.2 CAR-T (CT041) in Patients with Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers

open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, pancreatic...

Active, not recruiting
Gastric Cancer
Pancreatic Cancer
Biological: CT041

Phase 1, Phase 2

CARsgen Therapeutics

Rochester, Minnesota, United States and 15 other locations

study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab in patients with metastatic KRAS G12D - mutated Pancreatic...

Enrolling
Pancreatic Ductal Adenocarcinoma (PDAC)
G12D Mutated KRAS
Drug: VS-7375
Drug: cetuximab

Phase 2

Verastem

Rochester, Minnesota, United States and 28 other locations

This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...

Enrolling
Metastatic Pancreatic Carcinoma
Stage IV Pancreatic Cancer AJCC v8
Drug: Pemigatinib
Procedure: Bone Scan

Phase 2

Sameek Roychowdhury

Rochester, Minnesota, United States and 108 other locations

TNG462-C102 is a Phase 1/2, open-label, multicenter study designed to determine the safety, tolerability, PK, PD, and preliminary antineoplastic acti...

Enrolling
Pancreatic Cancer Metastatic
PDAC - Pancreatic Ductal Adenocarcinoma
Drug: TNG462
Drug: gemcitabine/nab-paclitaxel

Phase 1, Phase 2

Tango Therapeutics
Tango Therapeutics

Rochester, Minnesota, United States and 17 other locations

The purpose of this study is to evaluate the safety and efficacy of an investigational RAS(ON) inhibitor administered as monotherapy or in combinatio...

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Adenocarcinoma Metastatic
Drug: daraxonrasib
Drug: nab-paclitaxel

Phase 3

Revolution Medicines
Revolution Medicines

Rochester, Minnesota, United States and 48 other locations

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only.

Enrolling
Resected Pancreatic Adenocarcinoma
PDAC - Pancreatic Ductal Adenocarcinoma
Drug: daraxonrasib

Phase 3

Revolution Medicines
Revolution Medicines

Rochester, Minnesota, United States and 77 other locations

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.

Active, not recruiting
PDAC - Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer
Drug: 5-fluorouracil
Drug: leucovorin

Phase 3

Revolution Medicines
Revolution Medicines

Rochester, Minnesota, United States and 59 other locations

The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON...

Enrolling
Gastrointestinal Cancer
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: gemcitabine
Drug: bevacizumab

Phase 1, Phase 2

Revolution Medicines
Revolution Medicines

Rochester, Minnesota, United States and 31 other locations

This is a Phase 2 study for nuzefatide pevedotin (BT5528) in adults with a specific type of pancreatic cancer called metastatic pancreatic...

Enrolling
Pancreatic Ductal Adenocarcinoma (PDAC)
Drug: nuzefatide pevedotin (BT5528)

Phase 2

BicycleTx

Rochester, Minnesota, United States and 7 other locations

in patients with locally advanced, unresectable, or metastatic cancer. Secondly, this study aims to explore the procedural/clinical safety o...

Enrolling
Pancreatic Cancer Non-resectable
Pancreatic Cancer Stage III
Device: EUS-Guided MWA Device
Banner Health

Rochester, Minnesota, United States and 6 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems